Please use this identifier to cite or link to this item: http://localhost:80/xmlui/handle/123456789/15934
Title: Effects of puerarin on lipopolysaccharide-induced myocardial dysfunction in isolated rat hearts
Authors: Zhang Shaojun
Xu Yanyan
Chen Jian
Zheng Xia
Fang qiang
Jiang Saiping
Keywords: Puerarin
Myocardial dysfunction
Lipopolysaccharide
TNF-α.
Issue Date: 20-Jul-2017
Publisher: Karachi: Pakistan Botanical Society, University of Karachi
Citation: Shaojun, Z., Yanyan, X., Jian, C., Xia, Z., & Saiping, J. (2017). Effects of puerarin on lipopolysaccharide-induced myocardial dysfunction in isolated rat hearts. Pakistan Journal of Pharmaceutical Sciences, 30(4).
Abstract: Myocardial dysfunction is a serious complication induced by sepsis. Puerarin is an oriental medicine that possesses therapeutic benefits for cardiovascular diseases. The aim of this study was to evaluate the anti-myocardial dysfunction effects of puerarin in isolated rat hearts induced by lipopolysaccharide- and compare the myocardial protective effects between the different concentrations of puerarin. Isolated hearts were attached to a Langendorff apparatus and perfused with lipopolysaccharide (LPS) and different concentrations of puerarin. The hemodynamic parameters of heart rate (HR), left ventricular end systolic pressure [LVESP], +dp/dtmax, and −dp/dtmax were recorded. The biochemical indexes of lactic dehydrogenase (LDH), tumor necrosis factor alpha (TNF-α), and creatine kinase (CK) in the coronary effluent were measured at 40, 90, and 120 min of perfusion. TNF-α in myocardial tissues was measured after perfusion was completed. As a result, puerarin (0.24 mmol/L–0.48 mmol/L) significantly increased LVESP, +dp/dtmax, −dp/dtmax, and HR in isolated rat hearts that were declined by LPS during perfusion periods. Puerarin could protect against increased LDH, CK, and TNF-α in coronary effluent of isolated rat hearts by LPS during perfusion periods. Treatment of 0.48 mmol/L puerarin significantly decreased the TNF-α in coronary effluent of isolated rat hearts compared with the treatment of 0.12 and 0.24 mmol/L puerarin, but the TNF-α values were not reverted to baseline levels. However, the difference of TNF-α in myocardial tissue in the three puerarin-combined groups was statistically significant. This study confirms that puerarin can improve LPS-induced contractile dysfunction in isolated heart and inhibit LPS-stimulated myocardial TNF-α production.
URI: http://142.54.178.187:9060/xmlui/handle/123456789/15934
ISSN: 1011-601X
Appears in Collections:No.3 July 2017

Files in This Item:
File Description SizeFormat 
Paper-1.htm131 BHTMLView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.